Document Detail


Neuroleptic malignant syndrome-like, or--dopaminergic malignant syndrome--due to levodopa therapy withdrawal. Clinical features in 11 patients.
MedLine Citation:
PMID:  12573874     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A clinical picture named neuroleptic malignant-like syndrome has been described in patients with Parkinson's disease (PD) who suddenly stop their L-dopa treatment. The sudden withdrawal of the drug is deemed to lead to an acute deficiency stage in a patient who has an iatrogenic increase of dopaminergic transmission. We present a series of 11 patients with PD with an average age of 72.09 years, a mean disease duration of 9.45 years who developed this problem after a 92.72 h latency period. If patients with PD develop severe rigidity, stupor and hyperthermia, L-dopa withdrawal should be suspected and the dopaminergic drug restarted as soon as possible.
Authors:
Marcos Serrano-Dueñas
Related Documents :
14616294 - Three-dimensional computerized analysis of diadochokinetic movements of parkinsonian pa...
19425084 - Homocysteine levels after acute levodopa intake in patients with parkinson's disease.
17872984 - Using the presence of visual hallucinations to differentiate parkinson's disease from a...
16483454 - Falls in parkinson's disease. causes and impact on patients' quality of life.
15362734 - Prevention of bile leak after major hepatectomy.
271464 - The adult orthodontic patient.
Publication Detail:
Type:  Case Reports; Comparative Study; Journal Article    
Journal Detail:
Title:  Parkinsonism & related disorders     Volume:  9     ISSN:  1353-8020     ISO Abbreviation:  Parkinsonism Relat. Disord.     Publication Date:  2003 Jan 
Date Detail:
Created Date:  2003-02-07     Completed Date:  2003-04-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9513583     Medline TA:  Parkinsonism Relat Disord     Country:  England    
Other Details:
Languages:  eng     Pagination:  175-8     Citation Subset:  IM    
Affiliation:
Servicio de Neurología del Hospital Carlos Andrade Marín and Facultad de Medicina de la Pontificia, Universidad Catolica del Ecuador, PO Box 17-03-1694, Quito, Ecuador. serranom@pi.pro.ec
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Analysis of Variance
Diagnosis, Differential
Female
Humans
Levodopa / adverse effects*
Male
Middle Aged
Neuroleptic Malignant Syndrome / diagnosis*,  drug therapy,  physiopathology
Parkinson Disease / drug therapy,  physiopathology
Substance Withdrawal Syndrome / diagnosis*,  drug therapy,  physiopathology
Chemical
Reg. No./Substance:
0/Levodopa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Freezing of gait in multiple system atrophy (MSA).
Next Document:  Are electrophysiological autonomic tests useful in the assessment of dysautonomia in Parkinson's dis...